Claassen, Eric

Risk in vaccine research and development quantified

Pronker, E. S., Weenen, T. C., Commandeur, H., Claassen, E. H. J. H. M., & Osterhaus, A. D. M. E. (2013) · PLoS ONE

Pharmaceutical Economics and PolicyBiotechnology and Related Fields

Cited by 253

The underexposed role of food matrices in probiotic products: Reviewing the relationship between carrier matrices and product parameters

Flach, J., van der Waal, M. B., van den Nieuwboer, M., Claassen, E., & Larsen, O. F. A. (2018) · Critical Reviews in Food Science and Nutrition

Probiotics and Fermented FoodsMicroencapsulation and Drying Processes

Cited by 131

The development of probiotic treatment in obesity: a review

Mekkes, M. C., Weenen, T. C., Brummer, R. J., & Claassen, E. (2014) · Beneficial Microbes

Probiotics and Fermented FoodsGut microbiota and health

Cited by 87

Safety of probiotics and synbiotics in children under 18 years of age

van den Nieuwboer, M., Brummer, R. J., Guarner, F., Morelli, L., Cabana, M., & Claassen, E. (2015) · Beneficial Microbes

Probiotics and Fermented FoodsInfant Nutrition and Health

Cited by 83

Adopting health apps, what's hindering doctors and patients?

Dehzad, F., Hilhorst, C., de Bie, C., & Claassen, E. (2014) · Health

Mobile Health and mHealth ApplicationsHealth, Technology, Consumer Behavior

Cited by 46